What is the primary action of ACE inhibitors in the body?

What is the primary action of ACE inhibitors in the body?

• A. They increase the secretion of angiotensin II
• B. They stimulate the production of renin
• C. They prevent the conversion of angiotensin I to angiotensin II
• D. They block aldosterone secretion

Answer: (C)

The primary action of ACE inhibitors is to prevent the conversion of angiotensin I to angiotensin II. This mechanism is crucial for regulating blood pressure and fluid balance in the body. Angiotensin II is a potent vasoconstrictor that increases blood pressure and stimulates aldosterone secretion from the adrenal glands, which leads to sodium and water retention. By inhibiting the enzyme angiotensin-converting enzyme (ACE), these medications decrease the production of angiotensin II, resulting in vasodilation, reduced blood pressure, and decreased workload on the heart. This is particularly beneficial in treating conditions such as hypertension and heart failure. The other choices relate to processes that ACE inhibitors do not primarily influence. For instance, these medications do not increase the secretion of angiotensin II; rather, they reduce it. They also do not stimulate renin production, which is primarily affected by other regulatory pathways in the body. Lastly, while aldosterone secretion is impacted indirectly through the reduction of angiotensin II levels, blocking its secretion is not the main action of ACE inhibitors.

The primary action of ACE inhibitors is to prevent the conversion of angiotensin I to angiotensin II. This mechanism is crucial for regulating blood pressure and fluid balance in the body. Angiotensin II is a potent vasoconstrictor that increases blood pressure and stimulates aldosterone secretion from the adrenal glands, which leads to sodium and water retention. By inhibiting the enzyme angiotensin-converting enzyme (ACE), these medications decrease the production of angiotensin II, resulting in vasodilation, reduced blood pressure, and decreased workload on the heart. This is particularly beneficial in treating conditions such as hypertension and heart failure.

The other choices relate to processes that ACE inhibitors do not primarily influence. For instance, these medications do not increase the secretion of angiotensin II; rather, they reduce it. They also do not stimulate renin production, which is primarily affected by other regulatory pathways in the body. Lastly, while aldosterone secretion is impacted indirectly through the reduction of angiotensin II levels, blocking its secretion is not the main action of ACE inhibitors.